WallStreetZenWallStreetZen

How to Buy Insmed Stock

Insmed Inc

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases.

Insmed stock last closed at $24.80, down 0.48% from the previous day, and has increased 28.1% in one year. It has overperformed other stocks in the Biotechnology industry by 0.5 percentage points. Insmed stock is currently +37.13% from its 52-week low of $18.09, and -22.5% from its 52-week high of $32.00.

As of Apr 26, 2024, there are 148.49M shares of INSM outstanding. The market cap of INSM is $3.68B. In the past 24 hours, 1.29M INSM shares were traded.

How to Buy Insmed Stock

Wondering how to invest in Insmed stock? Here's how.
  1. Figure out where to buy Insmed stock: You need to pick a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you choose where to buy Insmed stock.
  2. Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
  3. Deposit funds into your brokerage account: Choose your method of payment and add your information.
  4. Analyze Insmed stock: The Insmed ticker symbol is INSM. Is Insmed stock a good investment? Should you buy shares of INSM? How do INSM's underlying business fundamentals look? Do top analysts think Insmed is a good buy? Why has INSM's stock price moved recently? (Hint: Our stock market analysis website can help you understand if INSM is a good stock to buy).
  5. Place your INSM buy order: Decide if you will purchase INSM shares at the current market price or use a limit order to purchase INSM shares at a given price.
  6. Get updates on your investment in INSM: Create a watchlist to key updates about your investment in Insmed stock.

Step 1: Figure out where to buy Insmed stock

You will need a brokerage account to access the NASDAQ market and buy INSM stock.

A brokerage account is an investment account that allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

Based on our experience, eToro is the best brokerage. Here's why:

  • You can invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
  • Access to world markets: From Technology to Real Estate, New York to Hong Kong — you can fill your portfolio with stocks from the globe's leading stock exchanges.
  • Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of stock by signing up for an account with eToro today.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for your brokerage account

Now that you've selected the best brokerage, it's time to fill out some personal details so you can buy INSM stock today.

How to Set Up a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal info to open a new trading account.
  1. Send your data by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your brokerage account

Now that you have filled out your info on the best stock broker app, your next step is to transfer the money for your investment:

Watch the video below for more details transferring funds into your brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Insmed stock

Once you have identified the best place to buy Insmed stock, it's very important to evaluate their stock prior to buying, so you actually comprehend the risk as well as the upside.

Insmed shares at a glance

INSM Price
$24.80
1w %
1.97%
1y %
28.1%
5y %
-19.92%
P/E
-4.64x
P/B
-11.09x
P/S
11.41x
PEG
N/A
Revenue
$305.21M
Earnings
-$749.57M
Fore. Rev. Growth
37.2%
Fore. Earn. Growth
N/A
Market Cap
$3.68B
Next Earnings
May 9, 2024
Next Dividend
N/A

INSM Due Diligence Checks

WallStreetZen was created to help average investors perform better fundamental analysis.

You can view all of the due diligence checks on INSM's stock page.

Is INSM stock undervalued or overvalued?

Analysts use a variety of different financial metrics, analyses, models, and charts to gauge INSM's fair value.

You can access additional valuation research on INSM's stock here.

Is INSM a healthy company?

Passed Financial Due Diligence Checks:

  • INSM has cash burn of 549535000. It has enough cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than short-term liabilities on the INSM balance sheet.

Failed Financial Due Diligence Checks:

  • INSM profit margin has gone down from -196.3% to -245.6% in the past year.
  • There are more long-term liabilities than short-term assets on the INSM balance sheet.
  • Total INSM debt is still negative.
  • INSM debt to equity ratio of -5.01 is negative.
  • INSM has $780.45M in cash and short term investments. This is not enough to cover its annual cash burn of $549.54M.

Do analysts think it's a good time to buy Insmed stock

Out of 7 sell side analysts who track INSM, the consensus analyst rating on Insmed is a Strong Buy

It's important to note that analyst ratings are not stock recommendations, nor are they investment advice.

Latest INSM Analyst Recommendations

Andy Chen, a top 26% analyst from Wolfe Research initiates coverage on INSM with a buy rating and announces their INSM price target of $42.00, on Feb 15, 2024.

Jessica Fye, a top 12% analyst from JP Morgan reinstates INSM with a strong buy rating and announces their INSM price target of $36.00, on Nov 20, 2023.

You can dig deeper into what analysts are saying on the Insmed stock forecast page.

INSM Momentum

SMA10
25.32
SMA20
26.46
SMA50
27.1
SMA100
27.85
SMA200
25.84
MACD
-0.66
MACD Signal
-0.48
MACD Histogram
-0.18
RSI
39.32
Stochastic %K
31.98
Stochastic %D
32.26
StochRSI %K
37.93
StochRSI %D
35.37

INSM Growth Numbers

Last year, INSM revenue was $305.21M. In the last five year, INSM's revenue has grown by 98.78% per year. This was faster than the Biotechnology industry average of 28.56%.

Dig into INSM's earnings and revenue performance here.

Who is buying/selling INSM?

In the last 12 months, executives and large shareholders at INSM have bought more shares than they have sold.

William Lewis, Chair and CEO of INSM, was the latest INSM insider to buy. They bought $629,000.00 worth of INSM shares on Feb 28, 2024.

Get more info about who owns INSM stock here.

Does INSM provide a stable income stream?

No, Insmed doesn't provide an income stream by paying out dividends.

INSM Social Trading Data

One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to learn what other traders have to say.

Step 5: Place your INSM buy order

There are two primary types of orders:

  • Market order: A market order is an order to buy or sell a stock at the best price on the market.
    Market orders are mostly fine for most investors.
  • Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
    If you want to make sure you're buying or selling at an exact price limit, place a limit order.

Hit the Open button and eToro will execute your order.

If you want more info about buying stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Get updates on your investment in INSM

Now that you own some shares in INSM, you'll want to keep up with your new investment.

Start a watchlist to get notified of important updates regarding your INSM stock.

INSM Feed

How to Buy Stock in Insmed

To summarize, here are the 6 steps you need to take to buy Insmed stock right now:

  1. Figure out where to buy Insmed stock
  2. Sign up for your brokerage account
  3. Deposit funds into your brokerage account
  4. Analyze Insmed stock
  5. Place your INSM buy order
  6. Get updates on your investment in INSM

If you are looking for a brokerage account, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to keep tabs on your new investment in Insmed, get started below.

NASDAQ: INSM
$24.80-0.12 (-0.48%)
Updated Apr 26, 2024
Open eToro Account
NASDAQ: INSM
$24.80-0.12 (-0.48%)
Updated Apr 26, 2024
Open eToro Account

FAQ

How much does it cost to buy one Insmed share?

As of Apr 26, 2024, it costs $24.80 to buy one share of Insmed stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.403 shares of INSM.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Insmed stock?

According to 7 Wall Street analysts who monitor Insmed, their consensus recommendation is to buy Insmed stock.

What is the best way to buy Insmed stock?

One way to place an order for Insmed stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.